Coronavirus medicine: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir for Covid-19

Written informed consent of each patient is required before the use of remdesivir and results of additional clinical trials, active post-marketing surveillance data and reporting of serious adverse events have to be submitted.

from The Financial Express https://ift.tt/2NiVewJ
https://ift.tt/eA8V8J PTI